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change the National Kidney Foundation guidelines recom-
mending early start (estimated glomerular ﬁltration rate over
10ml/min per m2) fail to consider the fact that dialyzer
clearances have not been shown to relate to patient survival in
two randomized controlled trials.2 Indeed it is illogical to
think that small-molecule dialyzer clearance provides a more
signiﬁcant beneﬁt than a patient’s own residual renal function,
which provides middle molecular as well as other kidney-
speciﬁc beneﬁts. Early dialysis leads to loss of this important
predictor of survival and is another reason why we caution
the nephrology community to examine the wisdom of the
trend to start dialysis early.
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The Authors Reply: We read with interest the report
‘Milky ascites is not always chylous’,1 in which the authors
attribute milky ascites in a patient with calciﬁed sclerosing
peritonitis to massive intraperitoneal amounts of calcium-
hydroxyphosphate–apatite crystals and colloidal calcium-
phosphate–fetuin-A complexes (calciprotein particles). We
have some questions, as this is at most a seldom presentation
of encapsulating peritoneal sclerosis (EPS).2,3 First, the
authors mention that the patient’s peritoneal permeability
was suggestive of sclerosing peritonitis. Although this does
not seem unlikely given both a long-term exposure to
peritoneal dialysis (PD) and the peritoneal calciﬁcations, a
diagnosis of EPS relies on clinical and radiological grounds:
bouts of recurrent, intermittent, or persisting episodes of
intestinal obstructions2,3 with, on computed tomography
scan, the presence of peritoneal thickening and calciﬁcations,
bowel wall thickening, tethering and bowel dilations, and
intra-abdominal ﬂuid loculations.4 Did this patient have
clinical or radiological evidence of EPS? Second, more data
on ascites volume, density, and concentration of other
constituents (creatinine, protein, etc.) could determine
whether the patient is having compartmentalized ascites
(‘loculation’), with no exchanges across the peritoneal
membrane, or ‘dynamic’ recently generated ascites. The
former, but not the latter, might explain the markedly
elevated concentrations of calciprotein particles. Finally,
it would have been of interest to test in vitro, in a test tube,
the apparition of a similar ‘milky’ coloration by mixing
huge amounts of calciprotein particles with a PD used
efﬂuent.
Given the increasing incidence of EPS,2,3 more data from
the present case might help clinicians to recognize this
complication.
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Tunnelled dialysis catheter
tip migration in obese and
large-breasted individuals:
an alternative tunnelling
technique as partial solution
to the problem
To the Editor: In his article, Karam1 describes the case of an
obese woman with cephalad migration of the tunneled
catheter tip, due to the movements of her large breast. We
have observed four similar cases, with repeated catheter
migration despite different tunnel sites, or suture of the
Dacron cuff to the subcutaneous tissue. An alternative
solution has proven efﬁcacious in preventing catheter
migration, using a double catheter with separate channeliza-
tion of its two external extremities (marked as c and d in
Figure 1). The surgical technique differs, as a short skin
incision (b) allows the intermediate exit of the twin catheters,
using the manufacturer’s tunneler; a second tunneler allows
for two separate exit sites. In this way, the reversed-Y
morphology provides stable catheter ﬁxation, precluding its
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